Traitement adjuvant du mélanome : étude comparative de survie en vie réelle à partir d’une base nationale
M. Vuillemey(Centre Hospitalier Universitaire de Nantes), G. Quéreux(Centre National de la Recherche Scientifique), P. Celérier(Centre Hospitalier de La Rochelle), Y. Le Corre(Centre Hospitalier Universitaire d'Angers), A. Khammari(Inserm), L. Misery(Centre Hospitalier Régional Universitaire de Brest), T. Goronflot(Centre Hospitalier Universitaire de Nantes), Julie Cassecuel(Centre Hospitalier Universitaire de Nantes), E. Hainault(Centre Jean Bernard), A. Dupuy(Hôpital Pontchaillou)
Cited by 0
Related Papers
Prospective Multicenter Study of Pegylated Liposomal Doxorubicin Treatment in Patients With Advanced or Refractory Mycosis Fungoides or Sézary Syndrome
|Archives of Dermatology|2008|103
GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis
|British Journal of Dermatology|2018|84
Management and outcome of metastatic melanoma during pregnancy
|British Journal of Dermatology|2009|71
Modulatory effects of selenium and strontium salts on keratinocyte-derived inflammatory cytokines
|Archives of Dermatological Research|1995|66
Long-Term Interferon-Alpha Therapy Induces Autoantibodies against Epidermis
|Dermatology|2009|64